Related Experiment Video
Updated: Jul 21, 2025

10:28
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
15.2K
Artificial intelligence for dementia-Applied models and digital health
Donald M Lyall1, Andrey Kormilitzin2, Claire Lancaster3
1School of Health and Wellbeing, College of Medical and Veterinary Sciences, University of Glasgow, Glasgow, UK.
Summary
Applied modeling and digital health technologies show promise for improving dementia risk prediction and diagnosis. These advanced methods, using multi-omics data, offer greater predictive power than traditional scores.
Area of Science:
- Computational neuroscience
- Geriatric medicine
- Biostatistics
Background:
- Applied modeling and digital health technologies are increasingly important for dementia risk prediction, diagnosis, and prognosis.
- Deep phenotyping cohorts with multi-omics data are becoming available, offering new opportunities for research.
Purpose of the Study:
- To synthesize the understanding of applied models and digital health technologies for dementia.
- To review their application in risk prediction, diagnostic discrimination, prognosis, and progression.
Main Methods:
- This is a narrative review.
- It synthesizes current understanding of applied models and digital health technologies in dementia research.
Main Results:
- Machine learning models demonstrate superior predictive power for dementia compared to standard clinical risk scores.
- These models can simplify complex datasets by identifying critical predictors.
Conclusions:
- Future advancements will benefit from improved data sharing, integration of multi-omics and electronic health records, and remote data measurement.
- Focus is shifting towards predicting secondary outcomes like treatment response and physical health, alongside primary dementia prediction.
More Related Videos
Related Concept Videos
Issues And Trends In Healthcare Delivery System
5.7K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
5.7K
Dementia
139
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
139
Alzheimer's Disease: Treatment
219
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
219
Alzheimer's Disease: Overview
524
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
524

